Last reviewed · How we verify
NCT07279038: SEQUOIA-3
Pivotal U.S. Clinical Validation of AI-COA® for Depression and Anxiety
trial in Depression Disorders in 650 participants. Not yet recruiting.
28 August 2029
Quick facts
| Lead sponsor | Deliberate Solutions Inc. |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 650 |
| Start date | 1 March 2027 |
| Primary completion | 28 August 2029 |
| Estimated completion | 28 August 2029 |
| Sites | 1 location across United States |
Conditions studied
- Depression Disorders — all drugs for Depression Disorders →
- Anxiety Disorders — all drugs for Anxiety Disorders →
Sponsor
Deliberate Solutions Inc.
Who can join
Adults 18 to 65, any sex, with Depression Disorders or Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is a large-scale pivotal clinical validation of the AI-COA® software device. The purpose is to confirm the tool's accuracy and performance across a demographically diverse population of adults with Major Depressive Disorder (MDD), ensuring it functions fairly and reliably across different subgroups.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07279038
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression Disorders
Currently open trials in the same condition.
- NCT06793397 — A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder · Phase 3 · recruiting
- NCT07174947 — SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depre · Phase 2 · recruiting
- NCT07082998 — Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression · NA · recruiting
- NCT07107906 — Evaluating and Implementing The CONNECT Program - a Group-Based Telehealth Intervention to Reduce Social Isolation, Lone · NA · recruiting
- NCT06923995 — Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity · NA · recruiting
Other Deliberate Solutions Inc. trials
Trials by the same sponsor.
- NCT07279025 — Validate the Temporal Stability and Responsiveness of AI-COA® for Depression and Anxiety · not yet recruiting
- NCT06923995 — Expansion and Evaluation of AI-generated Clinical Assessment (AI-COA®) of Depression and Anxiety Severity · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07279038 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Deliberate Solutions Inc.
- Last refreshed: 12 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07279038.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing